Generic Contrast Agents – Now You Have a Choice

Visit Fresenius Kabi to learn more. Booth #3235 

Fresenius Kabi has expanded their radiology portfolio to include additional cost-effective products, including the CT and MRI contrast agents featured in their booth this year at RSNA 2024.

In today’s world, having only one source of supply can be challenging. Keep your options open by expanding your choices. Diversify your options with a leading provider of generic injectable pharmaceuticals.

QR CodeBy partnering with Fresenius Kabi, you will have access to FDA-approved generic contrast agents that are fully substitutable to the brand-name products – at a lower cost. Now you have a choice.

Learn more about available generic contrast agents from Fresenius Kabi at GenericContrastAgents.com or scan the code to view their contrast agents product catalog. 


Fresenius Kabi at a Glance

Fresenius Kabi is a global health care company that specializes in essential medicines and technologies for infusion, transfusion and clinical nutrition – with a comprehensive portfolio of injectable drugs and delivery systems used to treat a broad spectrum of patients.

We are committed to putting essential medicines and technologies in the hands of health care providers. We work together to find the best answers to the challenges faced in providing quality patient care. We leverage our 100-year history so that clinicians can deliver therapies in ways that are safe, effective and affordable.

For more information about Fresenius Kabi, visit fresenius-kabi.com/us/

 

Around the web

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.

And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.